How GLP-1 penetration is reshaping the baseline
GLP-1 drugs now touch roughly 23 percent of US households, according to Circana data cited in the editor brief. Food Dive projects that figure reaching 35 percent by 2030. Those two numbers alone signal a structural shift in the eating occasion, not a passing trend.
But the more important commercial signal sits outside that 23 percent. Shoppers who have never taken a GLP-1 drug are still changing their baskets because the cultural conversation around appetite suppression, protein density, and smaller portions has normalised those choices for the broader population. Prior shopper intelligence from this publication noted that GLP-1 has made "higher protein, more fibre, and smaller portions feel mainstream" well beyond the drug-using cohort. That halo effect is where the volume opportunity sits for most brands, because GLP-1 users themselves represent a revolving population: earlier analysis on this pillar found that more than half of users stop within a year, so the basket shift you are trying to serve is broader than the prescription base.
The practical implication: your health positioning cannot be built solely around GLP-1 users as a named segment. It has to work for anyone who has absorbed the cultural message that eating less, eating cleaner, and eating more protein is what thoughtful shoppers do now.
Where protein demand is moving fastest
Protein is the clearest expression of health-as-default on the shelf today. In the sweets and snacks aisle, a category not historically associated with functional nutrition, dollar sales of products carrying 20 grams or more of protein grew 19 percent year over year in the 52 weeks ending March 22, 2026, per Spins data presented at the Sweets and Snacks Expo. Products with 10 to 20 grams of protein grew 13 percent in the same period. Products with less than 10 grams grew only 3 percent. The gradient is clear: the higher the protein count, the faster the growth.
Younger and older shoppers are reaching for protein in different ways. Younger shoppers over-index on added-protein formats such as PepsiCo's Protein Doritos, while older consumers gravitate toward naturally protein-rich options like yogurt and meat snacks, according to Scott Dicker, senior director of market insights at Spins. That split matters for your range architecture. A single protein hero SKU will not serve both cohorts. You need formats and pack sizes that speak to the "added function" framing younger shoppers want and the "naturally good" framing older shoppers trust.
How the basket is shifting toward smaller and functional formats
Smaller pack sizes and single-portion formats are gaining ground from two directions at once. GLP-1 users eat less per occasion and are less likely to finish a standard pack, so smaller formats reduce waste and improve the value perception of the purchase. But even outside that cohort, cost pressure is pushing shoppers toward smaller units as a way to control spending without abandoning a brand entirely.
Thailand-based supplement maker JSP Pharmaceutical, which generated roughly 800 million baht in sales in 2025, is responding to exactly this dynamic by launching functional FMCG products before the end of 2026, targeting younger consumers in both domestic and international markets, per Bangkok Post reporting. The move from healthcare to functional FMCG reflects where margin and growth now sit: not in traditional supplement aisles, but in mainstream grocery formats that carry a health benefit.
For CPG brands, the practical signal is that functional benefit and convenient portion size are converging. A product that is both high in protein and available in a single-serve format answers two shopper concerns simultaneously. That combination also supports a higher per-unit price without requiring shoppers to commit to a large outlay upfront.
What retailers are doing with the health signal
Retailers are adjusting range and shelf communication to reflect the health filter shoppers bring to the fixture. The pretzel category shows how this plays out even in a salty snack set. Dollar sales in pretzels reached $2.9 billion in the 52 weeks ended March 22, up 3.6 percent, with unit sales rising 1.2 percent, per Circana data reported by Food Business News. Hershey's Dot's Homestyle Pretzels posted $625.68 million in dollar sales over the same period, up 17 percent year over year, with unit sales jumping 19 percent. Bold flavors are driving that growth, but the broader category context is that snack brands competing on flavor innovation are also competing against functional alternatives for the same shopper attention. A pretzel that adds protein or fibre can now win on both dimensions.
On the health and wellness shelf more narrowly, specialty retailers like Sprouts are giving protein soda and high-protein yogurt formats prominent placement, a signal that functional positioning is being treated as a range-defining criterion rather than a niche call. Retailers building loyalty programmes around personalisation, as noted in prior pieces on Tesco Clubcard and Kroger Boost, are also using health-preference data to serve targeted offers on protein and fibre products to households that have already shown that intent.
How brands are activating against the health default
The brand moves worth watching are the ones that treat protein and functional benefit as a baseline claim rather than a premium upsell. PepsiCo's Protein Doritos targets younger shoppers who want indulgence and function in one format. Hain Celestial has extended high-protein variants across Greek Gods yogurt and its baby-and-toddler range, reaching both adult and family-nutrition occasions. JSP is building functional FMCG as a new category adjacent to its core supplement business, betting that mainstream grocery channels carry more growth than specialist health retail.
The activation insight across these moves is consistency of claim. Shoppers who have absorbed a health filter do not need persuading that protein matters. They need to find it quickly, trust the quantity stated on pack, and feel the format fits the occasion, whether that is a single-serve gym bag snack or a family multipack with a per-portion callout.
Clean label is an adjacent signal reinforcing the same shopper behaviour. Short ingredient lists and recognisable inputs are now expected alongside functional claims, not instead of them. Brands that carry a high protein count but a long, unfamiliar ingredient deck are running into shopper friction at the point of decision.
What to watch next
Three forward signals are worth building into your planning now.
First, oral GLP-1 drugs. Prior analysis on this pillar noted a clinical trial showing patients switching from injectable GLP-1s to the oral pill orforglipron retained 75 to 79 percent of the weight they had lost, compared with 38 to 49 percent for placebo. If lower-cost oral formats extend appetite suppression for years rather than months, the assumption that most GLP-1 users eventually return to old eating patterns no longer holds. The single-serve, high-protein, lower-calorie format would shift from a niche to the dominant occasion.
Second, fibre. Protein has captured most of the commercial attention so far, but fibre demand is growing alongside it. UK retail data cited in prior pillar coverage showed the gut-health market growing at 45 percent year on year. Brands that can credibly carry both a protein and a fibre claim on the same pack are better positioned for the next phase of shopper filtering.
Third, demographic segmentation within the health trend. Gen Z over-indexes on added-protein formats and reads health through an identity and performance lens. Older shoppers are pulling healthy-ageing nutrition into mainstream grocery. Those are not the same shopper and they do not respond to the same pack communication. Your health activation plan needs to make that distinction explicit, or you will end up with messaging that speaks clearly to neither cohort.
The floor has moved. Health is not a reason to buy up from a standard option. For a growing share of the shopper base, it is the condition a product must meet before it earns consideration at all.